Jagsonpal Pharmaceuticals Ltd.

₹235.02

Jagsonpal Pharmaceuticals Ltd.

  • NSE : JAGSNPHARM

₹235.02

₹235.02

-3.11 (-1.31%) - 12 Jun 2025 04:15 PM
  • NSE : JAGSNPHARM

About Company

Jagsonpal Pharmaceutical is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities. Founded in 1964 the company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. The firm is committed to sustainable growth and is aggressively pursuing growth through market penetration, market expansion and multi-national expansion. The firm’s objective is to increase market share and become a dominant player in the Indian Pharmaceutical Industry. Jagsonpal has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe making it a truly international operation. The company’s operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam making Jagsonpal’s reach truly global.

Market Cap. ₹ 1,554 Cr.
52 Week - High/Low ₹ 328/130
P/E Ratio 41.25
P/B Ratio 7.99
Enterprise Value ₹ 1,360 Cr.
ROE % 14.02
RSI Value 55.27
EMA 50 224.19
EMA 200 212.12
Market Cap. ₹ 1,554 Cr.
52 Week - High/Low ₹ 328/130
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value -
ROE % N/A
RSI Value 55.27
EMA 50 224.19
EMA 200 212.12

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.